Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness

Australian and New Zealand Journal of Psychiatry

Volumn 51, Issue 4, 2017, Pages 322-337

  Lambert, Timothy J R ^a,b   Reavley, Nicola J ^c   Jorm, Anthony F ^c   Oakley Browne, Mark A ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cardiometabolic; guidelines; multi morbidity; Psychosis; schizophrenia

Indexed keywords

CLOZAPINE; PSYCHOTROPIC AGENT;

ADVERSE DRUG REACTION; ANXIETY; ARTICLE; CANCER RISK; CARDIOMETABOLIC RISK; CAREGIVER; COMORBIDITY; CONSENSUS; CONSUMER; DELPHI STUDY; DENTAL HEALTH; DEPRESSION; HEALTH CARE QUALITY; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MENTAL HEALTH SERVICE; MORTALITY RATE; OBESITY; OSTEOPOROSIS; PATIENT EDUCATION; PHYSICAL DISEASE; PHYSICIAN; PSYCHOSIS; RESPIRATORY TRACT DISEASE; RISK FACTOR; SCREENING; TOBACCO USE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; ADULT; AUSTRALIA; COOPERATION; DISEASE MANAGEMENT; FEMALE; HEALTH CARE PERSONNEL; MALE; MENTAL DISORDERS; MIDDLE AGED; MORTALITY; NEW ZEALAND; PRACTICE GUIDELINE; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE;

ADULT; AUSTRALIA; CONSENSUS; COOPERATIVE BEHAVIOR; DELPHI TECHNIQUE; DISEASE MANAGEMENT; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEW ZEALAND; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; SURVEYS AND QUESTIONNAIRES;

EID: 85018356862     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867416686693     Document Type: Article

References (61)

1. Australian Bureau of Statistics (2013) Australian Health Survey: Updated Results, 2011-2012. Canberra, ACT, Australia: Australian Bureau of Statistics.
2. Babidge NC, Buhrich N, Butler T, (2001) Mortality among homeless people with schizophrenia in Sydney, Australia: A 10-year follow-up. Acta Psychiatrica Scandinavica 103: 105-110.
3. Berk L, Jorm AF, Kelly CM, et al. (2011) Development of guidelines for caregivers of people with bipolar disorder: A Delphi expert consensus study. Bipolar Disorders 13: 556-570.
4. Bobes J, Alegria AA, Saiz-Gonzalez MD, et al. (2011) Change in psychiatrists' attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia. European Psychiatry 26: 305-312.
5. Bobes-Garcia J, Saiz-Ruiz J, Bernardo-Arroyo M, et al. (2012) Delphi consensus on the physical health of patients with schizophrenia: Evaluation of the recommendations of the Spanish Societies of Psychiatry and Biological Psychiatry by a panel of experts. Actas Espanolas De Psiquiatria 40: 114-128.
6. Brown S, Inskip H, Barraclough B, (2000) Causes of the excess mortality of schizophrenia. British Journal of Psychiatry 177: 212-217.
7. Burgers J, Grol R, Eccles M, (2005). Clinical guidelines as a tool for implementing change in patient care. In: Grol R, Wensing M, Eccles M, Improving Patient Care: The implementation of change in clinical practice. Oxford: Elsevier. pp. 71-92.
8. Citrome L, Yeomans D, (2005) Do guidelines for severe mental illness promote physical health and well-being? Journal of Psychopharmacology 19: 102-109.
9. Cohn TA, Sernyak MJ, (2006) Metabolic monitoring for patients treated with antipsychotic medications. Canadian Journal of Psychiatry 51: 492-501.
10. Cooper J, Mancuso SG, Borland R, et al. (2012) Tobacco smoking among people living with a psychotic illness: The second Australian Survey of Psychosis. Australian and New Zealand Journal of Psychiatry 46: 851-863.
11. Curtis J, Henry C, Watkins A, et al. (2011) Metabolic abnormalities in an early psychosis service: A retrospective, naturalistic cross-sectional study. Early Intervention in Psychiatry 5: 108-114.
12. De Hert M, Correll CU, Bobes J, et al. (2011a) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10: 52-77.
13. De Hert M, van Eyck D, De Nayer A, (2006) Metabolic abnormalities associated with second generation antipsychotics: Fact or fiction? Development of guidelines for screening and monitoring. International Clinical Psychopharmacology 21 (Suppl. 2): S11-S15.
14. De Hert M, Vancampfort D, Correll CU, et al. (2011b) Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: Systematic evaluation. British Journal of Psychiatry 199: 99-105.
15. De Nayer A, De Hert M, Scheen A, et al. (2005) Belgian consensus on metabolic problems associated with atypical antipsychotics. International Journal of Psychiatry in Clinical Practice 9: 130-137.
16. Dinan TG, (2004) Schizophrenia and diabetes 2003: An expert consensus meeting. Introduction. British Journal of Psychiatry Supplement 47: S53-S54.
17. Downar J, Delaney JW, Hawryluck L, et al. (2016) Guidelines for the withdrawal of life-sustaining measures. Intensive Care Medicine 42: 1003-1017.
18. Foley DL, Morley KI, (2011) Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Archives of General Psychiatry 68: 609-616.
19. Foley DL, Mackinnon A, Watts GF, et al. (2013) Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS ONE 8: e82606.
20. Galletly CA, Castle D, Dark F, et al. (2016) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry 50: 410-472.
21. Galletly CA, Foley DL, Waterreus A, et al. (2012) Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry 46: 753-761.
22. Gladigau EL, Fazio TN, Hannam JP, et al. (2014) Increased cardiovascular risk in patients with severe mental illness. Internal Medicine Journal 44: 65-69.
23. Goff DC, Cather C, Evins AE, et al. (2005) Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists. Journal of Clinical Psychiatry 66: 183-194; quiz 147, 273-184.
24. Gothefors D, Adolfsson R, Attvall S, et al. (2010) Swedish clinical guidelines-prevention and management of metabolic risk in patients with severe psychiatric disorders. Nordic Journal of Psychiatry 64: 294-302.
25. Grimshaw JM, Thomas RE, MacLennan G, et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment 8: iii-iv, 1-72.
26. John AP, Koloth R, Dragovic M, et al. (2009) Prevalence of metabolic syndrome among Australians with severe mental illness. Medical Journal of Australia 190: 176-179.
27. Jones J, Hunter D, (1995) Consensus methods for medical and health services research. British Medical Journal 311: 376-380.
28. Jorm AF, (2015) Using the Delphi expert consensus method in mental health research. Australian and New Zealand Journal of Psychiatry 49: 887-897.
29. Kane JM, Barrett EJ, Casey DE, et al. (2004) Metabolic effects of treatment with atypical antipsychotics. Journal of Clinical Psychiatry 65: 1447-1455.
30. Kelly CM, Jorm AF, Kitchener BA, et al. (2008) Development of mental health first aid guidelines for suicidal ideation and behaviour: A Delphi study. BMC Psychiatry 8: 17.
31. Kisely S, Campbell LA, Wang Y, (2009) Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. British Journal of Psychiatry 195: 545-550.
32. Koppen H, Stolwijk J, Wilms EB, et al. (2016) Cardiac monitoring of high-dose verapamil in cluster headache: An international Delphi study. Cephalalgia 36: 1385-1388.
33. Lambert TJ, (2009) The medical care of people with psychosis. Medical Journal of Australia 190: 171-172.
34. Lambert TJ, Newcomer JW, (2009) Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Medical Journal of Australia 190: S39-S42.
35. Lambert TJ, Chapman LH, and Consensus Working Group (2004) Diabetes, psychotic disorders and antipsychotic therapy: A consensus statement. Medical Journal of Australia 181: 544-548.
36. Lambert TJ, Velakoulis D, Pantelis C, (2003) Medical comorbidity in schizophrenia. Medical Journal of Australia 178 (Suppl.): S67-S70.
37. Langlands RL, Jorm AF, Kelly CM, et al. (2008) First aid for depression: A Delphi consensus study with consumers, carers and clinicians. Journal of Affective Disorders 105: 157-165.
38. Lawrence D, Hancock KJ, Kisely S, (2013) The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: Retrospective analysis of population based registers. BMJ 346: f2539.
39. Lawrence D, Jablensky AV, Holman CD, et al. (2000) Mortality in Western Australian psychiatric patients. Social Psychiatry and Psychiatric Epidemiology 35: 341-347.
40. Marmot MG, (2004) Evidence based policy or policy based evidence? British Medical Journal 328: 906-907.
41. Mental Health Commission (2012) Blueprint II: Improving Mental Health and Wellbeing for All New Zealanders-How Things Need to Be. Wellington: Mental Health Commission.
42. Ministry of Health (2012) Rising to the Challenge: The Mental Health and Addiction Service Development Plan 2012-2017. Wellington: Ministry of Health. Available at: www.health.govt.nz
43. Mitchell AJ, (2012) Understanding disproportionately high cardiometabolic risk in Australians treated for psychosis. Australian and New Zealand Journal of Psychiatry 46: 919-920.
44. Mitchell AJ, Vancampfort D, Sweers K, et al. (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-A systematic review and meta-analysis. Schizophrenia Bulletin 39: 306-318.
45. Moore E, Mancuso SG, Slade T, et al. (2012) The impact of alcohol and illicit drugs on people with psychosis: The second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry 46: 864-878.
46. Morgan VA, McGrath JJ, Jablensky A, et al. (2014) Psychosis prevalence and physical, metabolic and cognitive co-morbidity: Data from the second Australian national survey of psychosis. Psychological Medicine 44: 2163-2176.
47. Murphy NK, Black NA, Lamping DL, et al. (1998) Consensus development methods, and their use in clinical guideline development. Health Technology Assessment 2: i-iv, 1-88.
48. National Institute of Clinical Studies (NICS) (2006) Do Guidelines Make a Difference to Healthcare Outcomes? Melbourne, VIC, Australia: NICS.
49. National Mental Health Commission (2012) A Contributing Life: The 2012 National Report Card. Sydney, NSW, Australia: National Mental Health Commission.
50. New South Wales (NSW) Department of Health (2009) Physical Health Care of Mental Health Consumers. Sydney, NSW, Australia: NSW Department of Health.
51. Powell BJ, McMillen JC, Proctor EK, et al. (2012) A compilation of strategies for implementing clinical innovations in health and mental health. Medical Care Research and Review 69: 123-157.
52. Royal Australian and New Zealand College of Psychiatrists (RANZCP) (2005) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry 39: 1-30.
53. Saha S, Chant D, McGrath J, (2007) A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry 64: 1123-1131.
54. Schleedoorn MJ, Nelen WL, Dunselman GA, et al. (2016) Selection of key recommendations for the management of women with endometriosis by an international panel of patients and professionals. Human Reproduction. Epub ahead of print 24 April. DOI: 10.1093/humrep/dew078.
55. Stanley S, Laugharne J, (2010) Clinical Guidelines for the Physical Care of Mental Health Consumers. Perth, WA, Australia: Community, Culture and Mental Health Unit, School of Psychiatry and Clinical Neurosciences, The University of Western Australia.
56. Strasser K, Moeller-Saxone K, Meadows G, et al. (2002) Smoking cessation in schizophrenia. General practice guidelines. Australian Family Physician 31: 21-24.
57. Stubbs B, Vancampfort D, De Hert M, et al. (2015) The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: A systematic review and comparative meta-analysis. Acta Psychiatrica Scandinavica 132: 144-157.
58. Van Hasselt FM, Oud MJ, Loonen AJ, (2015) Practical recommendations for improvement of the physical health care of patients with severe mental illness. Acta Psychiatrica Scandinavica 131: 387-396.
59. Van Winkel R, De Hert M, Van Eyck D, et al. (2006) Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: Evaluation of incidence and screening methods. Journal of Clinical Psychiatry 67: 1493-1500.
60. Vancampfort D, Mitchell AJ, De Hert M, et al. (2015) Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: A systematic review and meta-analysis. Journal of Clinical Psychiatry 76: 1490-1499.
61. Walker ER, McGee RE, Druss BG, (2015) Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry 72: 334-341.